A photo-activated aptamer-drug conjugate for targeted drug delivery. 2022

Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China. xjliu@iccas.ac.cn.

A photo-activated aptamer-drug conjugate, HG1-9-DNP, was developed based on an aptamer HG1-9 and a photolabile naphthalimide derivative DNP. HG1-9-DNP could be internalized into cells mediated by TfR, then photocleaved, and released a promising cytotoxic agent, DNNH, which arrested the cell cycle at the G2/M phase, resulting in high photo-induced cytotoxicity.

UI MeSH Term Description Entries
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D052157 Aptamers, Nucleotide Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity. DNA Aptamer,DNA Aptamers,RNA Aptamers,Rna Aptamer,Nucleotide Aptamers,Oligonucleotide Ligands, DNA,Oligonucleotide Ligands, RNA,Aptamer, DNA,Aptamer, Rna,Aptamers, DNA,Aptamers, RNA,DNA Oligonucleotide Ligands,RNA Oligonucleotide Ligands
D053644 Naphthalimides Compounds with three fused rings that appear like a naphthalene fused to piperidone or like a benz(de)isoquinoline-1,3-dione (not to be confused with BENZYLISOQUINOLINES which have a methyl separating the naphthyl from the benzyl rings). Members are CYTOTOXINS. Naphthalimide

Related Publications

Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
January 2018, International journal of nanomedicine,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
December 2006, Angewandte Chemie (International ed. in English),
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
December 2013, Biomaterials,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
April 2016, Leukemia,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
April 2024, Journal of controlled release : official journal of the Controlled Release Society,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
January 2022, Frontiers in cellular and infection microbiology,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
February 2018, Cancer research,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
February 2011, Oligonucleotides,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
May 2012, Journal of pharmaceutical sciences,
Jing Liu, and Xiangjun Liu, and Mengwen Yi, and Yue Sun, and Tao Bing, and Nan Zhang, and Dihua Shangguan
March 2010, ACS nano,
Copied contents to your clipboard!